These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

72 related articles for article (PubMed ID: 15757292)

  • 1. [The role of leukotrienes in inflammatory process in cystic fibrosis].
    Korzeniewska A; Stelmach I
    Pneumonol Alergol Pol; 2004; 72(1-2):52-5. PubMed ID: 15757292
    [No Abstract]   [Full Text] [Related]  

  • 2. Oxidative stress and lipid-derived inflammatory mediators during acute exacerbations of cystic fibrosis.
    Reid DW; Misso N; Aggarwal S; Thompson PJ; Walters EH
    Respirology; 2007 Jan; 12(1):63-9. PubMed ID: 17207027
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Airway inflammation in cystic fibrosis].
    Derelle J
    Rev Prat; 2003 Jan; 53(2):141-4. PubMed ID: 12664844
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Oxidation reactions catalyzed by cytochrome P-450 on fatty acids and leukotrienes: implications in inflammatory mechanisms].
    Delaforge M; Reigneau O
    Ann Med Interne (Paris); 1988; 139(7):492-8. PubMed ID: 3245648
    [No Abstract]   [Full Text] [Related]  

  • 5. Inflammation and CFTR: might neutrophils be the key in cystic fibrosis?
    Witko-Sarsat V; Sermet-Gaudelus I; Lenoir G; Descamps-Latscha B
    Mediators Inflamm; 1999; 8(1):7-11. PubMed ID: 10704083
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inflammation in cystic fibrosis--when and why? Friend or foe?
    Elston C; Geddes D
    Semin Respir Crit Care Med; 2007 Jun; 28(3):286-94. PubMed ID: 17562498
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lipid inflammatory mediators: leukotrienes, prostaglandins, platelet-activating factor.
    Christie PE; Henderson WR
    Clin Allergy Immunol; 2002; 16():233-54. PubMed ID: 11577541
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Leukotrienes and inflammatory lung disease.
    Piper PJ; Conroy DM; Costello JF; Evans JM; Green CP; Price JF; Sampson AP; Spencer DA
    Ann N Y Acad Sci; 1991; 629():112-9. PubMed ID: 1952542
    [No Abstract]   [Full Text] [Related]  

  • 9. Infection, inflammation, and the downward spiral of cystic fibrosis lung disease.
    Moss RB
    J Pediatr; 2009 Feb; 154(2):162-3. PubMed ID: 19150671
    [No Abstract]   [Full Text] [Related]  

  • 10. Introduction to section I: overview of approaches to study cystic fibrosis pathophysiology.
    Clunes MT; Boucher RC
    Methods Mol Biol; 2011; 742():3-14. PubMed ID: 21547723
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mechanisms of Disease: leukotrienes and lipoxins in scleroderma lung disease--insights and potential therapeutic implications.
    Kowal-Bielecka O; Kowal K; Distler O; Gay S
    Nat Clin Pract Rheumatol; 2007 Jan; 3(1):43-51. PubMed ID: 17203008
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Leukotrienes and inflammation.
    Busse WW
    Am J Respir Crit Care Med; 1998 Jun; 157(6 Pt 2):S210-3; discussion S247-8. PubMed ID: 9647601
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nitric oxide, iNOS, and inflammation in cystic fibrosis.
    Downey D; Elborn JS
    J Pathol; 2000 Feb; 190(2):115-6. PubMed ID: 10657007
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The role of secretory leucoprotease inhibitor in the resolution of inflammatory responses.
    Weldon S; McGarry N; Taggart CC; McElvaney NG
    Biochem Soc Trans; 2007 Apr; 35(Pt 2):273-6. PubMed ID: 17371258
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impairment of mucociliary transport in cystic fibrosis.
    Newhouse MT; Rossman CM; Dolovich J; Dolovich MB; Wilson WM
    Mod Probl Paediatr; 1976 Oct 24-27; 19():190-8. PubMed ID: 1031907
    [No Abstract]   [Full Text] [Related]  

  • 16. Relationships between cystic fibrosis transmembrane conductance regulator, extracellular nucleotides and cystic fibrosis.
    Marcet B; Boeynaems JM
    Pharmacol Ther; 2006 Dec; 112(3):719-32. PubMed ID: 16828872
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Accumulation of ceramide in the trachea and intestine of cystic fibrosis mice causes inflammation and cell death.
    Becker KA; Tümmler B; Gulbins E; Grassmé H
    Biochem Biophys Res Commun; 2010 Dec; 403(3-4):368-74. PubMed ID: 21078296
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Additional functions for the cysteinyl leukotrienes recognized through studies of inflammatory processes in null strains.
    Austen KF
    Prostaglandins Other Lipid Mediat; 2007 May; 83(3):182-7. PubMed ID: 17481553
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Do the cysteine proteinases cathepsin B and S contribute to cystic fibrosis lung disease?
    Grasemann H
    Pediatr Pulmonol; 2010 Sep; 45(9):845-6. PubMed ID: 20632408
    [No Abstract]   [Full Text] [Related]  

  • 20. Role of IKK and ERK pathways in intrinsic inflammation of cystic fibrosis airways.
    Verhaeghe C; Remouchamps C; Hennuy B; Vanderplasschen A; Chariot A; Tabruyn SP; Oury C; Bours V
    Biochem Pharmacol; 2007 Jun; 73(12):1982-94. PubMed ID: 17466952
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.